These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Assessment of a commercial sandwich ELISA in the diagnosis of aspergillosis in falcons. Arca-Ruibal B; Wernery U; Zachariah R; Bailey TA; Di Somma A; Silvanose C; McKinney P Vet Rec; 2006 Apr; 158(13):442-4. PubMed ID: 16581995 [TBL] [Abstract][Full Text] [Related]
31. Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. Dupont B; Huber M; Kim SJ; Bennett JE J Infect Dis; 1987 Jan; 155(1):1-11. PubMed ID: 3098861 [TBL] [Abstract][Full Text] [Related]
32. Multicenter evaluation of an enzyme immunoassay (Platelia Aspergillus) for the detection of Aspergillus antigen in serum. Lombardi G; Farina C; Andreoni S; D'Antonio D; Faggi E; Manso E; Mazzoni A Mycopathologia; 2002; 155(3):129-33. PubMed ID: 12617498 [TBL] [Abstract][Full Text] [Related]
33. [The use of galactomannan detection in diagnosing invasive aspergillosis in hemato-oncological patients]. Rácil Z; Kocmanová I; Wagnerová B; Winterová J; Lengerová M; Moulis M; Mayer J Vnitr Lek; 2008 Jan; 54(1):45-52. PubMed ID: 18390117 [TBL] [Abstract][Full Text] [Related]
34. The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergilosis (IPA). Siemann M; Koch-Dörfler M Mycoses; 2001; 44(7-8):266-72. PubMed ID: 11714060 [TBL] [Abstract][Full Text] [Related]
35. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. Walsh TJ; Shoham S; Petraitiene R; Sein T; Schaufele R; Kelaher A; Murray H; Mya-San C; Bacher J; Petraitis V J Clin Microbiol; 2004 Oct; 42(10):4744-8. PubMed ID: 15472335 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. White PL; Parr C; Thornton C; Barnes RA J Clin Microbiol; 2013 May; 51(5):1510-6. PubMed ID: 23486712 [TBL] [Abstract][Full Text] [Related]
37. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis. Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577 [TBL] [Abstract][Full Text] [Related]
38. Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children. Dinand V; Anjan M; Oberoi JK; Khanna S; Yadav SP; Wattal C; Sachdeva A J Microbiol Immunol Infect; 2016 Feb; 49(1):66-73. PubMed ID: 24582464 [TBL] [Abstract][Full Text] [Related]
39. Serial Aspergillus antigen monitoring in pediatric bone marrow transplant patients. Baker C J Pediatr Oncol Nurs; 2006; 23(6):300-4. PubMed ID: 17035619 [TBL] [Abstract][Full Text] [Related]
40. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Bretagne S; Costa JM; Bart-Delabesse E; Dhédin N; Rieux C; Cordonnier C Clin Infect Dis; 1998 Jun; 26(6):1407-12. PubMed ID: 9636871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]